IL-33 precedes IL-5 in regulating eosinophil commitment and is required for eosinophil homeostasis

Journal of Immunology

Volumn 197, Issue 9, 2016, Pages 3445-3453

  Johnston, Laura K ^a   Hsu, Chia Lin ^a   Krier Burris, Rebecca A ^a   Chhiba, Krishan D ^a   Chien, Karen B ^a   McKenzie, Andrew ^b   Berdnikovs, Sergejs ^a   Bryce, Paul J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 33; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR ALPHA; NEUTRALIZING ANTIBODY; IL1RL1 PROTEIN, MOUSE; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN; INTERLEUKIN-5- RECEPTOR ALPHA, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BONE MARROW; BONE MARROW CELL; CELL ISOLATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HOMEOSTASIS; HYPEREOSINOPHILIA; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIESIS; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; EOSINOPHILS; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HOMEOSTASIS; HUMANS; INTERLEUKIN-1 RECEPTOR-LIKE 1 PROTEIN; INTERLEUKIN-33; INTERLEUKIN-5; INTERLEUKIN-5 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS;

EID: 84992397254     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600611     Document Type: Article

References (44)

1. Rothenberg, M. E., and S. P. Hogan. 2006. The eosinophil. Annu. Rev. Immunol. 24: 147-174.
2. Rosenberg, H. F., K. D. Dyer, and P. S. Foster. 2013. Eosinophils: changing perspectives in health and disease. Nat. Rev. Immunol. 13: 9-22.
3. Iwasaki, H., S. Mizuno, R. Mayfield, H. Shigematsu, Y. Arinobu, B. Seed, M. F. Gurish, K. Takatsu, and K. Akashi. 2005. Identification of eosinophil lineage-committed progenitors in the murine bone marrow. J. Exp. Med. 201: 1891-1897.
4. Sanderson, C. J., D. J. Warren, and M. Strath. 1985. Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures. J. Exp. Med. 162: 60-74.
5. Kopf, M., F. Brombacher, P. D. Hodgkin, A. J. Ramsay, E. A. Milbourne, W. J. Dai, K. S. Ovington, C. A. Behm, G. Köhler, I. G. Young, and K. I. Matthaei. 1996. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4: 15-24.
6. Dent, L. A., M. Strath, A. L. Mellor, and C. J. Sanderson. 1990. Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med. 172: 1425-1431.
7. Byström, J., T. A. Wynn, J. B. Domachowske, and H. F. Rosenberg. 2004. Gene microarray analysis reveals interleukin-5-dependent transcriptional targets in mouse bone marrow. Blood 103: 868-877.
8. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
9. Löhning, M., A. Stroehmann, A. J. Coyle, J. L. Grogan, S. Lin, J. C. Gutierrez-Ramos, D. Levinson, A. Radbruch, and T. Kamradt. 1998. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl. Acad. Sci. USA 95: 6930-6935.
10. Suzukawa, M., M. Iikura, R. Koketsu, H. Nagase, C. Tamura, A. Komiya, S. Nakae, K. Matsushima, K. Ohta, K. Yamamoto, and M. Yamaguchi. 2008. An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J. Immunol. 181: 5981-5989.
11. Neill, D. R., S. H. Wong, A. Bellosi, R. J. Flynn, M. Daly, T. K. Langford, C. Bucks, C. M. Kane, P. G. Fallon, R. Pannell, et al. 2010. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464: 1367-1370.
12. Morita, H., K. Arae, H. Unno, S. Toyama, K. Motomura, A. Matsuda, H. Suto, K. Okumura, K. Sudo, T. Takahashi, et al. 2015. IL-25 and IL-33 contribute to development of eosinophilic airway inflammation in epicutaneously antigen-sensitized mice. PLoS One 10: e0134226.
13. Nakanishi, W., S. Yamaguchi, A. Matsuda, M. Suzukawa, A. Shibui, A. Nambu, K. Kondo, H. Suto, H. Saito, K. Matsumoto, et al. 2013. IL-33, but not IL-25, is crucial for the development of house dust mite antigen-induced allergic rhinitis. PLoS One 8: e78099.
14. Tjota, M. Y., J. W. Williams, T. Lu, B. S. Clay, T. Byrd, C. L. Hrusch, D. C. Decker, C. A. de Araujo, P. J. Bryce, and A. I. Sperling. 2013. IL-33-dependent induction of allergic lung inflammation by FcgRIII signaling. J. Clin. Invest. 123: 2287-2297.
15. Chu, D. K., A. Llop-Guevara, T. D. Walker, K. Flader, S. Goncharova, J. E. Boudreau, C. L. Moore, T. Seunghyun In, S. Waserman, A. J. Coyle, R. Kolbeck, A. A. Humbles, and M. Jordana. 2013. IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J. Allergy Clin. Immunol. 131: 187-200. e1-e8.
16. Wills-Karp, M., R. Rani, K. Dienger, I. Lewkowich, J. G. Fox, C. Perkins, L. Lewis, F. D. Finkelman, D. E. Smith, P. J. Bryce, et al. 2012. Trefoil factor 2 rapidly induces interleukin 33 to promote type 2 immunity during allergic asthma and hookworm infection. J. Exp. Med. 209: 607-622.
17. Stolarski, B., M. Kurowska-Stolarska, P. Kewin, D. Xu, and F. Y. Liew. 2010. IL-33 exacerbates eosinophil-mediated airway inflammation. J. Immunol. 185: 3472-3480.
18. Dyer, K. D., C. M. Percopo, and H. F. Rosenberg. 2013. IL-33 promotes eosinophilia in vivo and antagonizes IL-5-dependent eosinophil hematopoiesis ex vivo. Immunol. Lett. 150: 41-47.
19. Kurowska-Stolarska, M., B. Stolarski, P. Kewin, G. Murphy, C. J. Corrigan, S. Ying, N. Pitman, A. Mirchandani, B. Rana, N. van Rooijen, et al. 2009. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol. 183: 6469-6477.
20. Macias, M. P., L. A. Fitzpatrick, I. Brenneise, M. P. McGarry, J. J. Lee, and N. A. Lee. 2001. Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice. J. Clin. Invest. 107: 949-959.
21. Elmore, S. A. 2006. Enhanced histopathology of the bone marrow. Toxicol. Pathol. 34: 666-686.
22. Smuda, C., J. B. Wechsler, and P. J. Bryce. 2011. TLR-induced activation of neutrophils promotes histamine production via a PI3 kinase dependent mechanism. Immunol. Lett. 141: 102-108.
23. Le, H., W. Kim, J. Kim, H. R. Cho, and B. Kwon. 2013. Interleukin-33: a mediator of inflammation targeting hematopoietic stem and progenitor cells and their progenies. Front. Immunol. 4: 104.
24. Enoksson, M., C. Möller-Westerberg, G. Wicher, P. G. Fallon, K. Forsberg-Nilsson, C. Lunderius-Andersson, and G. Nilsson. 2013. Intraperitoneal influx of neutrophils in response to IL-33 is mast cell-dependent. Blood 121: 530-536.
25. Dyer, K. D., K. E. Garcia-Crespo, K. E. Killoran, and H. F. Rosenberg. 2011. Antigen profiles for the quantitative assessment of eosinophils in mouse tissues by flow cytometry. J. Immunol. Methods 369: 91-97.
26. Mita, S., S. Takaki, A. Tominaga, and K. Takatsu. 1993. Comparative analysis of the kinetics of binding and internalization of IL-5 in murine IL-5 receptors of high and low affinity. J. Immunol. 151: 6924-6932.
27. Lee, N. A., M. P. McGarry, K. A. Larson, M. A. Horton, A. B. Kristensen, and J. J. Lee. 1997. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J. Immunol. 158: 1332-1344.
28. Dyer, K. D., J. M. Moser, M. Czapiga, S. J. Siegel, C. M. Percopo, and H. F. Rosenberg. 2008. Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J. Immunol. 181: 4004-4009.
29. Bouffi, C., A. V. Kartashov, K. L. Schollaert, X. Chen, W. C. Bacon, M. T. Weirauch, A. Barski, and P. C. Fulkerson. 2015. Transcription factor repertoire of homeostatic eosinophilopoiesis. J. Immunol. 195: 2683-2695.
30. Linch, S. N., E. T. Danielson, A. M. Kelly, R. A. Tamakawa, J. J. Lee, and J. A. Gold. 2012. Interleukin 5 is protective during sepsis in an eosinophil-independent manner. Am. J. Respir. Crit. Care Med. 186: 246-254.
31. Saluja, R., M. Khan, M. K. Church, and M. Maurer. 2015. The role of IL-33 and mast cells in allergy and inflammation. Clin. Transl. Allergy 5: 33.
32. Oboki, K., T. Ohno, N. Kajiwara, H. Saito, and S. Nakae. 2010. IL-33 and IL-33 receptors in host defense and diseases. Allergol. Int. 59: 143-160.
33. Kim, J., W. Kim, H. T. Le, U. J. Moon, V. G. Tran, H. J. Kim, S. Jung, Q. T. Nguyen, B. S. Kim, J. B. Jun, et al. 2014. IL-33-induced hematopoietic stem and progenitor cell mobilization depends upon CCR2. J. Immunol. 193: 3792-3802.
34. Moussion, C., N. Ortega, and J. P. Girard. 2008. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One 3: e3331.
35. Mager, L. F., C. Riether, C. M. Schürch, Y. Banz, M. H. Wasmer, R. Stuber, A. P. Theocharides, X. Li, Y. Xia, H. Saito, et al. 2015. IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms. J. Clin. Invest. 125: 2579-2591.
36. Hsu, C. L., C. V. Neilsen, and P. J. Bryce. 2010. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One 5: e11944.
37. Smith, S. G., A. Gugilla, M. Mukherjee, K. Merim, A. Irshad, W. Tang, T. Kinoshita, B. Watson, J. P. Oliveria, M. Comeau, et al. 2015. Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma. J. Allergy Clin. Immunol. 135: 1594-1602.
38. Allakhverdi, Z., M. R. Comeau, D. E. Smith, D. Toy, L. M. Endam, M. Desrosiers, Y. J. Liu, K. J. Howie, J. A. Denburg, G. M. Gauvreau, and G. Delespesse. 2009. CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. J. Allergy Clin. Immunol. 123: 472-478.
39. Nussbaum, J. C., S. J. Van Dyken, J. von Moltke, L. E. Cheng, A. Mohapatra, A. B. Molofsky, E. E. Thornton, M. F. Krummel, A. Chawla, H. E. Liang, and R. M. Locksley. 2013. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502: 245-248.
40. Brickshawana, A., V. S. Shapiro, H. Kita, and L. R. Pease. 2011. Lineage(-)Sca1+c-Kit(-)CD25+ cells are IL-33-responsive type 2 innate cells in the mouse bone marrow. J. Immunol. 187: 5795-5804.
41. Verri Jr., W. A., F. O. Souto, S. M. Vieira, S. C. Almeida, S. Y. Fukada, D. Xu, J. C. Alves-Filho, T. M. Cunha, A. T. Guerrero, R. B. Mattos-Guimaraes, et al. 2010. IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann. Rheum. Dis. 69: 1697-1703.
42. Talabot-Ayer, D., P. Martin, C. Vesin, C. A. Seemayer, S. Vigne, C. Gabay, and G. Palmer. 2015. Severe neutrophil-dominated inflammation and enhanced myelopoiesis in IL-33-overexpressing CMV/IL33 mice. J. Immunol. 194: 750-760.
43. Molfino, N. A., D. Gossage, R. Kolbeck, J. M. Parker, and G. P. Geba. 2012. Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor. Clin. Exp. Allergy 42: 712-737.
44. Nabe, T. 2014. Interleukin (IL)-33: new therapeutic target for atopic diseases. J. Pharmacol. Sci. 126: 85-91.